NCT00305305Recruiting
Brain Development Research Program
Disorders of Cerebral Development: A Phenotypic and Genetic Analysis
Source: ClinicalTrials.gov · Last updated 17 Aug 2026
Brief summary (registry, in English)
Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 17 Mar 2006
- Start date
- Aug 2003
- Primary completion date
- Jan 2027
- Lead sponsor
- University of California, San Francisco
- NCT number
- NCT00305305
What you commit to
- Study type: Observational
- Planned participants: 2000
- From Aug 2003 to the primary completion date, Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Fully formed but hypoplastic corpus callosum
Who the study is looking for
- Clinical diagnosis of agenesis or dysgenesis of the corpus callosum, polymicrogyria, or Dandy-Walker malformation
- Should be confirmed by an MRI (Magnetic Resonance Imaging) of the brain
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.